148 related articles for article (PubMed ID: 6608335)
1. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania.
Meltzer HY; Umberkoman-Wiita B; Robertson A; Tricou BJ; Lowy M; Perline R
Arch Gen Psychiatry; 1984 Apr; 41(4):366-74. PubMed ID: 6608335
[TBL] [Abstract][Full Text] [Related]
2. Enhanced serum cortisol response to 5-hydroxytryptophan in depression and mania.
Meltzer HY; Uberkoman-Wiita B; Robertson A; Tricou BJ; Lowy M
Life Sci; 1983 Dec; 33(25):2541-9. PubMed ID: 6645813
[TBL] [Abstract][Full Text] [Related]
3. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms.
Meltzer HY; Perline R; Tricou BJ; Lowy M; Robertson A
Arch Gen Psychiatry; 1984 Apr; 41(4):379-87. PubMed ID: 6608336
[TBL] [Abstract][Full Text] [Related]
4. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate.
Meltzer HY; Lowy M; Robertson A; Goodnick P; Perline R
Arch Gen Psychiatry; 1984 Apr; 41(4):391-7. PubMed ID: 6422900
[TBL] [Abstract][Full Text] [Related]
5. The cortisol responses to 5-hydroxytryptophan, orally, in depressive inpatients.
Maes M; De Ruyter M; Claes R; Bosma G; Suy E
J Affect Disord; 1987; 13(1):23-30. PubMed ID: 2959697
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol.
Meltzer HY
Ann N Y Acad Sci; 1984; 430():115-37. PubMed ID: 6378031
[No Abstract] [Full Text] [Related]
7. The relationships between the cortisol responses to dexamethasone and to L-5-HTP, and the availability of L-tryptophan in depressed females.
Maes M; Vandewoude M; Schotte C; Maes L; Martin M; Scharpe S; Blockx P
Biol Psychiatry; 1990 Mar; 27(6):601-8. PubMed ID: 2322619
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxytryptophan-induced cortisol response and CSF 5-HIAA in depressed patients.
Koyama T; Lowy MT; Meltzer HY
Am J Psychiatry; 1987 Mar; 144(3):334-7. PubMed ID: 2435178
[TBL] [Abstract][Full Text] [Related]
9. Effect of 5-hydroxytryptophan on H-reflex recovery curves in normal subjects and patients with affective disorders.
Metz JT; Holcomb HH; Meltzer HY
Biol Psychiatry; 1988 Mar; 23(6):602-11. PubMed ID: 3128339
[TBL] [Abstract][Full Text] [Related]
10. Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity.
Lykouras L; Markianos M; Hatzimanolis Y
Neuropsychobiology; 2011; 63(2):77-81. PubMed ID: 21178381
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders.
Yehuda R; Boisoneau D; Mason JW; Giller EL
Biol Psychiatry; 1993 Jul 1-15; 34(1-2):18-25. PubMed ID: 8373936
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid receptor function in major depression.
Young EA; Lopez JF; Murphy-Weinberg V; Watson SJ; Akil H
Arch Gen Psychiatry; 2003 Jan; 60(1):24-8. PubMed ID: 12511169
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.
Meltzer H; Bastani B; Jayathilake K; Maes M
Neuropsychopharmacology; 1997 Jul; 17(1):1-11. PubMed ID: 9194044
[TBL] [Abstract][Full Text] [Related]
14. L-5-hydroxytryptophan stimulated cortisol escape from dexamethasone suppression in melancholic patients.
Maes M; D'Hondt P; Martin M; Claes M; Schotte C; Vandewoude M; Blockx P
Acta Psychiatr Scand; 1991 Apr; 83(4):302-6. PubMed ID: 2028807
[TBL] [Abstract][Full Text] [Related]
15. Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls.
Stein MB; Uhde TW
Biol Psychiatry; 1988 Jul; 24(3):322-30. PubMed ID: 2840978
[TBL] [Abstract][Full Text] [Related]
16. Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission.
Maes M; Calabrese J; Jayathilake K; Meltzer HY
Psychiatry Res; 1997 Jul; 71(2):67-76. PubMed ID: 9255851
[TBL] [Abstract][Full Text] [Related]
17. Postsynaptic serotonergic activity in depressive patients: evaluation of the neuroendocrine strategy.
Westenberg HG; van Praag HM; de Jong JT; Thijssen JH
Psychiatry Res; 1982 Dec; 7(3):361-71. PubMed ID: 6984515
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC
Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder.
Jacobsen FM; Sack DA; Wehr TA; Rogers S; Rosenthal NE
Arch Gen Psychiatry; 1987 Dec; 44(12):1086-91. PubMed ID: 3500688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
